• Medication, Device, and Biologic Agents Testing and Selection

    The AAFP, at all times, supports rigorous pre- and post-market testing of drugs, devices, and biological agents. Testing should ensure safety as well as benefit measured by health outcomes of value to patients. Previously approved agents should be available for research or scientifically supported clinical use for "off label" indications. The selection of appropirate agents in treatment of an individual should take into consideration the scientific evidence alongside the patient's values and preferences in a shared decision-making process. (1977) (2018 COD)